Skip to main content

BRIEF RESEARCH REPORT article

Front. Med.
Sec. Precision Medicine
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1492851
This article is part of the Research Topic Case Reports in Tumor Genomics and ctDNA in Precision Medicine View all articles

Rare SRRM2 mutation in neurodevelopmental disorders involving hyperphagia triggering severe obesity and other complication

Provisionally accepted
SI-HUA CHANG SI-HUA CHANG 1*Xia Wang Xia Wang 2Jie-Yuan Jin Jie-Yuan Jin 1Qin Wang Qin Wang 2Li-Ping Wu Li-Ping Wu 3
  • 1 Central South University, Changsha, China
  • 2 Xiangya Hospital, Central South University, Changsha, Hunan Province, China
  • 3 Shenzhen Longgang District Maternal and Child Health Care Hospital, Shenzhen, China

The final, formatted version of the article will be published soon.

    SRRM2 encodes a nuclear protein, with functions in pre-mRNA splicing and the formation of nuclear speckles via liquid-liquid phase separation. Despite its critical role in cellular function, the association between SRRM2 and neurodevelopmental disorders is not well-understood. In this study, we reported a case of a patient exhibiting developmental delay, intellectual disability, delayed language development, facial dysmorphism, macrocephaly, short hands and feet, hyperphagia, and hypotonia, which are similar to the characteristics of previously reported cases of SRRM2-associated neurodevelopmental disorders. Notably, the patient became overweight and subsequently developed several obesity-related complications due to uncontrolled hyperphagia. Employing whole exome sequencing (WES) and Sanger sequencing, we identified a novel missense mutation in SRRM2 (NM_016333: c.4661A>T, p.Q1554L). This mutation is classified as "Likely Pathogenic" based on the American College of Medical Genetics and Genomics (ACMG) guideline. Overall, this study contributes to the expanding spectrum of known mutations in SRRM2, enhances our understanding of its clinical implications, and offers crucial data for the diagnosis and management of affected individuals

    Keywords: SRRM2, Neurodevelopmental disorders, Hyperphagia, Obesity, Intellectual Disability

    Received: 23 Dec 2024; Accepted: 30 Jan 2025.

    Copyright: © 2025 CHANG, Wang, Jin, Wang and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: SI-HUA CHANG, Central South University, Changsha, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.